Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane Armitage

Showing results (61-70 of 105) with videos related to

Pageof 11
Sort By:
Lancet (London, England)|September 25, 2017
Efficiency and safety of varying the frequency of whole blood donation (INTERVAL): a randomised trial of 45 000 donorsEmanuele Di Angelantonio, Simon G Thompson, Stephen Kaptoge, et al.
JAMA Network Open|December 28, 2021
Comparison of the Accuracy and Completeness of Records of Serious Vascular Events in Routinely Collected Data vs Clinical Trial-Adjudicated Direct Follow-up Data in the UK: Secondary Analysis of the ASCEND Randomized Clinical TrialCharlie Harper, Marion Mafham, William Herrington, et al.
Archives of Internal Medicine|July 11, 2007
Cholesterol fractions and apolipoproteins as risk factors for heart disease mortality in older menRobert Clarke, Jonathan R Emberson, Sarah Parish, et al.
Current Developments in Nutrition|May 14, 2023
Calcium Supplements and Risk of CVD: A Meta-Analysis of Randomized TrialsXiqian Huo, Robert Clarke, Jim Halsey, et al.
Heart (British Cardiac Society)|June 3, 2023
Reliability of major bleeding events in UK routine data versus clinical trial adjudicated follow-up dataCharlie Harper, Marion Mafham, William Herrington, et al.
European Heart Journal|February 22, 2024
Thromboxane biosynthesis and future events in diabetes: the ASCEND trialGiovanna Petrucci, Georgina A Buck, Bianca Rocca, et al.
The New England Journal of Medicine|July 12, 2014
Effects of extended-release niacin with laropiprant in high-risk patients, Martin J Landray, Richard Haynes, et al.
Ebiomedicine|April 25, 2018
Genomic Response to Vitamin D Supplementation in the Setting of a Randomized, Placebo-Controlled TrialAntonio J Berlanga-Taylor, Katharine Plant, Andrew Dahl, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 12, 2022
Weight loss in a cardiovascular trial population identifies people at future risk of dementiaPieter van der Veere, Imen Hammami, Georgina Buck, et al.
Pharmacoeconomics|February 24, 2023
Prediction Models for Individual-Level Healthcare Costs Associated with Cardiovascular Events in the UKJunwen Zhou, Runguo Wu, Claire Williams, et al.
Pageof 11

Showing results (61-70 of 105) with videos related to

Sort By:
Pageof 11
Lancet (London, England)|September 25, 2017
Efficiency and safety of varying the frequency of whole blood donation (INTERVAL): a randomised trial of 45 000 donorsEmanuele Di Angelantonio, Simon G Thompson, Stephen Kaptoge, et al.
JAMA Network Open|December 28, 2021
Comparison of the Accuracy and Completeness of Records of Serious Vascular Events in Routinely Collected Data vs Clinical Trial-Adjudicated Direct Follow-up Data in the UK: Secondary Analysis of the ASCEND Randomized Clinical TrialCharlie Harper, Marion Mafham, William Herrington, et al.
Archives of Internal Medicine|July 11, 2007
Cholesterol fractions and apolipoproteins as risk factors for heart disease mortality in older menRobert Clarke, Jonathan R Emberson, Sarah Parish, et al.
Current Developments in Nutrition|May 14, 2023
Calcium Supplements and Risk of CVD: A Meta-Analysis of Randomized TrialsXiqian Huo, Robert Clarke, Jim Halsey, et al.
Heart (British Cardiac Society)|June 3, 2023
Reliability of major bleeding events in UK routine data versus clinical trial adjudicated follow-up dataCharlie Harper, Marion Mafham, William Herrington, et al.
European Heart Journal|February 22, 2024
Thromboxane biosynthesis and future events in diabetes: the ASCEND trialGiovanna Petrucci, Georgina A Buck, Bianca Rocca, et al.
The New England Journal of Medicine|July 12, 2014
Effects of extended-release niacin with laropiprant in high-risk patients, Martin J Landray, Richard Haynes, et al.
Ebiomedicine|April 25, 2018
Genomic Response to Vitamin D Supplementation in the Setting of a Randomized, Placebo-Controlled TrialAntonio J Berlanga-Taylor, Katharine Plant, Andrew Dahl, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 12, 2022
Weight loss in a cardiovascular trial population identifies people at future risk of dementiaPieter van der Veere, Imen Hammami, Georgina Buck, et al.
Pharmacoeconomics|February 24, 2023
Prediction Models for Individual-Level Healthcare Costs Associated with Cardiovascular Events in the UKJunwen Zhou, Runguo Wu, Claire Williams, et al.
Pageof 11